SCARNA1 Plays Role in TrkB, P53 and FBN1 Interactions, Suggests Study

Target Name: SCARNA1

NCBI ID: G677774

SCARNA1

Other Name(s): ACA35 | Small Cajal body-specific RNA 1 | small Cajal body-specific RNA 1

SCARNA1 Plays Role in TrkB, P53 and FBN1 Interactions, Suggests Study

SCARNA1 (ACA35) is a protein that is expressed in various tissues throughout the body, including the nervous system, endocrine system, and immune system. It is a member of the SCARNA family of proteins, which are characterized by the presence of a specific domain known as the SCARNA-type 1 (ST1) domain. The ST1 domain is a type of transmembrane domain that is characterized by the presence of a conserved basic amino acid sequence that is commonly found in proteins that are involved in cell signaling and signaling pathways.

One of the unique features of SCARNA1 is its ability to interact with other proteins, particularly with the protein known as TrkB. TrkB is a transmembrane protein that is involved in the intracellular signaling pathway known as the T cell signaling pathway. This pathway is important for the regulation of immune responses and has been implicated in a number of diseases, including cancer, autoimmune diseases, and neurodegenerative diseases.

The interaction between SCARNA1 and TrkB has been shown to play a role in the regulation of a variety of cellular processes, including the regulation of cell growth, the regulation of protein synthesis, and the regulation of cell death. Additionally, the interaction between SCARNA1 and TrkB has been shown to be involved in the regulation of the expression of genes that are involved in the development and progression of cancer.

Another unique feature of SCARNA1 is its ability to interact with the protein known as p53. p53 is a well-known protein that is involved in the regulation of DNA replication and has been implicated in a number of diseases, including cancer. The interaction between SCARNA1 and p53 has been shown to play a role in the regulation of DNA replication and the development of cancer.

In addition to its interaction with TrkB and p53, SCARNA1 has also been shown to interact with a number of other proteins, including the protein known as FBN1. FBN1 is a protein that is involved in the regulation of blood clotting and has been implicated in a number of diseases, including heart disease and cancer. The interaction between SCARNA1 and FBN1 has been shown to play a role in the regulation of blood clotting and the development of cancer.

Overall, SCARNA1 (ACA35) is a protein that is characterized by its ability to interact with other proteins, particularly TrkB, p53, and FBN1. These interactions have been shown to play a role in the regulation of a variety of cellular processes, including the regulation of cell growth, the regulation of protein synthesis, the regulation of cell death, and the regulation of DNA replication and the development of cancer. As a result, SCARNA1 is a potential drug target and a biomarker for a variety of diseases.

Protein Name: Small Cajal Body-specific RNA 1

The "SCARNA1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCARNA1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets